Andrew Spaventa - Chief Executive Officer, Director at Singular Genomics Systems, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
OMIC on Nasdaq
Industry
Laboratory Analytical Instruments
All Insider Reports
All Insider Reports

Andrew Spaventa - trading volume in the past year for Singular Genomics Systems, Inc.

Holdings reported by Andrew Spaventa for Singular Genomics Systems, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 22.9K $455K $19.89 Feb 12, 2025 Direct Common Stock
Common Stock 0 $0 $19.89 Feb 21, 2025 By Axon Holdings, LLC
Common Stock 0 $0 $19.89 Feb 21, 2025 By The Andrew K. Spaventa Living Trust dated April 9, 2014
Common Stock 0 $0 $19.89 Feb 21, 2025 Direct
Restricted Stock Unit 0 $0 $20.00 Feb 21, 2025 Direct Common Stock
Stock Option (Right to Buy) 0 $0 $1.10 Feb 21, 2025 By The Andrew K. Spaventa Living Trust dated April 9, 2014 Common Stock

Transactions reported by Andrew Spaventa for Singular Genomics Systems, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.